WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006011397) DRUG FOR PREVENTION OR TREATMENT OF DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/011397    International Application No.:    PCT/JP2005/013287
Publication Date: 02.02.2006 International Filing Date: 20.07.2005
IPC:
A61K 31/4439 (2006.01), A61K 31/20 (2006.01), A61P 3/10 (2006.01), A61P 9/10 (2006.01), A61P 13/12 (2006.01), A61P 25/00 (2006.01)
Applicants: KOWA COMPANY., LTD. [JP/JP]; 6-29, Nishiki 3-chome, Naka-ku, Nagoya-shi, Aichi 4608625 (JP) (For All Designated States Except US).
INOUE, Keisuke [JP/JP]; (JP) (For US Only).
TAMAKI, Tarou [JP/JP]; (JP) (For US Only)
Inventors: INOUE, Keisuke; (JP).
TAMAKI, Tarou; (JP)
Agent: KAWAGUCHI, Yoshiyuki; Acropolis 21 Building 6th floor 4-10, Higashi Nihonbashi 3-chome Chuo-ku, Tokyo 1030004 (JP)
Priority Data:
60/591,505 27.07.2004 US
Title (EN) DRUG FOR PREVENTION OR TREATMENT OF DIABETES
(FR) MÉDICAMENT POUR LA PRÉVENTION OU LE TRAITEMENT DU DIABÈTE
(JA) 糖尿病の予防または治療のための薬剤
Abstract: front page image
(EN)A drug for the prevention or treatment of diabetes which contains 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid or a pharmacologically acceptable salt thereof and pioglitazone hydrochloride as active ingredients. Also provided is a method for the prevention or treatment of diabetes which comprises administering 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid or a pharmacologically acceptable salt thereof and pioglitazone hydrochloride to a patient who is ill with diabetes or may suffer from it.
(FR)L'invention concerne un médicament pour la prévention ou le traitement du diabète lequel contient de l'acide 2,2-dichloro-12-(4-chlorophényl)dodécanoïque ou un sel acceptable du point de vue pharmacologique de celui-ci et du chlorhydrate de pioglitazone comme ingrédients actifs. L'invention concerne également un procédé pour la prévention ou le traitement du diabète lequel comprend d'administrer de l'acide 2,2-dichloro-12-(4-chlorophényl)dodécanoïque ou un sel acceptable du point de vue pharmacologique de celui-ci et du chlorhydrate de pioglitazone à un patient qui souffre du diabète ou peut en souffrir.
(JA) 本発明は、2,2-ジクロロ-12-(4-クロロフェニル)-ドデカン酸またはその薬理学的に許容しうる塩と塩酸ピオグリタゾンとを有効成分とする糖尿病の予防または治療のための薬剤を提供するものである。また、本発明は、糖尿病を予防または治療するための方法であって、糖尿病になっている又はなる恐れのある患者に、2,2-ジクロロ-12-(4-クロロフェニル)-ドデカン酸またはその薬理学的に許容しうる塩と塩酸ピオグリタゾンとを投与することを含む、糖尿病を予防または治療するための方法を提供する。
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)